Sabra Healthcare REIT (NASDAQ:SBRA) Given New $22.00 Price Target at BMO Capital Markets

Key Points

• BMO Capital Markets has raised its target price for Sabra Healthcare REIT from $19.00 to $22.00, suggesting a potential price increase of 13.61% based on the stock's previous close.
• Sabra Healthcare REIT reported earnings of $0.38 per share, exceeding expectations, and has set its FY 2025 guidance at $1.450-1.470 EPS.
• Most analysts rate the stock as a "Moderate Buy," with a consensus price target of approximately $20.29.

Sabra Healthcare REIT (NASDAQ:SBRA - Free Report) had its price target hoisted by BMO Capital Markets from $19.00 to $22.00 in a research note published on Monday,Benzinga reports. BMO Capital Markets currently has a market perform rating on the real estate investment trust's stock.

Several other equities research analysts also recently commented on SBRA. Scotiabank lifted their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. JMP Securities lifted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $20.43.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA traded down $0.20 during trading hours on Monday, hitting $19.11. The company's stock had a trading volume of 2,586,825 shares, compared to its average volume of 2,763,639. Sabra Healthcare REIT has a 12 month low of $15.60 and a 12 month high of $20.03. The company's 50 day simple moving average is $18.56 and its two-hundred day simple moving average is $17.78. The company has a market cap of $4.58 billion, a P/E ratio of 25.15, a price-to-earnings-growth ratio of 1.54 and a beta of 0.86. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the company earned $0.36 EPS. Sabra Healthcare REIT's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts expect that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Institutional Trading of Sabra Healthcare REIT

Institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its stake in Sabra Healthcare REIT by 0.8% in the second quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust's stock worth $121,960,000 after purchasing an additional 55,200 shares during the period. Bank of New York Mellon Corp increased its stake in Sabra Healthcare REIT by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust's stock worth $76,988,000 after purchasing an additional 60,843 shares during the period. Northern Trust Corp increased its stake in Sabra Healthcare REIT by 27.7% in the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after purchasing an additional 905,466 shares during the period. Nuveen LLC purchased a new stake in Sabra Healthcare REIT in the first quarter worth $61,791,000. Finally, Janus Henderson Group PLC increased its stake in Sabra Healthcare REIT by 23.1% in the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock worth $60,720,000 after purchasing an additional 657,950 shares during the period. 99.40% of the stock is currently owned by institutional investors.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.